Company Filing History:
2 out of 15 
7 out of 832,912 Years Active: 2013-2024
Title: **Innovator Christopher Slawinski: Pioneering Noninvasive Glucose Analysis**
Introduction
Christopher Slawinski, based in Mesa, AZ, is a notable inventor with a remarkable portfolio of 12 patents. His pioneering work focuses on noninvasive methods for glucose concentration determination, contributing significantly to advancements in medical technology.
Latest Patents
Slawinski's latest innovations include two significant patents:
1. **Sample Position Resolved Noninvasive Glucose Concentration Determination Analyzer Apparatus and Method of Use Thereof**
This invention relates to a method and an apparatus designed to analyze a common tissue position, such as the dermis of a person's skin, for noninvasive analyte property determination. It involves probing the skin with various distances between illumination and detection zones across at least two overlapping wavelength ranges. The process aims to select optimal optical pathways while avoiding the subcutaneous fat layer.
2. **Common Sample Depth/Zone Noninvasive Glucose Concentration Determination Analyzer Apparatus and Method of Use Thereof**
This invention comprises a technique and device for sampling skin layers during the noninvasive determination of an analyte's properties. Utilizing a probe housing that includes a set of partially embedded detectors, together with distinct illumination zones, this apparatus facilitates data collection while targeting overlapping surface paths on common skin areas.
Career Highlights
Throughout his career, Christopher Slawinski has made significant contributions to the field of noninvasive glucose monitoring. His patents reflect a deep understanding of optical systems and biomedical applications, helping pave the way for more efficient and user-friendly glucose monitoring devices.
Collaborations
Slawinski has collaborated with notable professionals in the field, including Alan Abul-Haj and Kevin H Hazen, enhancing the collaborative effort towards innovative solutions in healthcare technologies.
Conclusion
Christopher Slawinski's innovations mark a vital step in noninvasive glucose monitoring, merging technology with healthcare. His patents not only showcase his inventive spirit but also the potential to improve the quality of life for many individuals managing diabetes. Through continued exploration and innovation, Slawinski aims to further advance the field of noninvasive health monitoring.